ORAMELT Trademark
ORAMELT is a USPTO trademark filed by BAUSCH HEALTH IRELAND LIMITED. Status: Cancelled.
Trademark Facts
| Mark | ORAMELT |
|---|---|
| Serial Number | 77543711 |
| Registration Number | 4247772 |
| Status | Cancelled |
| Filing Date | 2008-08-11 |
| Registration Date | 2012-11-27 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | BAUSCH HEALTH IRELAND LIMITED |
| Attorney of Record | Robert J. Gorman |
| Prosecution Events | 84 |
| Latest Event | ASCK on 2026-02-18 |
Goods & Services
Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of anxiety; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the cardiovascular system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of cardiopulmonary disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hypertension, angina, high blood pressure, heart failure and ventricular dysfunction; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of metabolic disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of diabetes; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of viral and infectious diseases; Drug delivery agents consisting of rapidly dissolving compounds, formulations, compositions and agents that facilitate delivery of a wide range of human and veterinary pharmaceuticals; and Drug delivery agents in the nature of pill coatings that facilitate delivery of a wide range of human and veterinary pharmaceuticals; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Tourette syndrome